Caspase-cleaved fragments of cytokeratin 18 in patients with chronic hepatitis B

Clinica Chimica Acta

Volumn 411, Issue 23-24, 2010, Pages 2029-2032

  Eren, Fatih ^a   Yilmaz, Yusuf ^c   Kose, Sukran ^d   Ozdemir, Filiz Ture ^a   Yonal, Oya ^c   Kurt, Ramazan ^c   Ozdogan, Osman ^c   Avsar, Erol ^a,b  

^a MARMARA UNIVERSITY   (Turkey)

^b Marmara University School of Medicine ^*

^c TEPECIK EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^d MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Apoptosis; Chronic hepatitis B; Cytokeratin 18; Inactive carriers

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CASPASE; CYTOKERATIN 18; HEPATITIS B(E) ANTIBODY; VIRUS DNA;

ADULT; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HEPATITIS B; HUMAN; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN FUNCTION; VIRUS CARRIER;

ANTIBODIES, MONOCLONAL; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CASPASES; FEMALE; HEPATITIS B, CHRONIC; HUMANS; KERATIN-18; LIVER; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; ROC CURVE;

HEPATITIS B VIRUS;

EID: 77957751505     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.08.035     Document Type: Article

References (19)

1. Najimi M., Smets F., Sokal E. Hepatocyte apoptosis. Methods Mol Biol 2009, 481:59-74.
2. Guicciardi M.E., Gores G.J. Apoptosis: a mechanism of acute and chronic liver injury. Gut 2005, 54:1024-1033.
3. Caulín C., Salvesen G.S., Oshima R.G. Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis. J Cell Biol 1997, 138:1379-1394.
4. Linder S., Havelka A.M., Ueno T., Shoshan M.C. Determining tumor apoptosis and necrosis in patient serum using cytokeratin 18 as a biomarker. Cancer Lett 2004, 214:1-9.
5. Kramer G., Erdal H., Mertens H.J., et al. Differentiation between cell death modes using measurements of different soluble forms of extracellular cytokeratin 18. Cancer Res 2004, 64:1751-1756.
6. Linder S. Cytokeratin markers come of age. Tumour Biol 2007, 28:189-195.
7. Gonzalez-Quintela A., Mallo N., Mella C., et al. Serum levels of cytokeratin-18 (tissue polypeptide-specific antigen) in liver diseases. Liver Int 2006, 26:1217-1224.
8. Yilmaz Y., Dolar E., Ulukaya E., et al. Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis. World J Gastroenterol 2007, 13:837-844.
9. Yilmaz Y. Systematic review: caspase-cleaved fragments of cytokeratin 18-the promises and challenges of a biomarker for chronic liver disease. Aliment Pharmacol Ther 2009, 30:1103-1109.
10. Bantel H., Lügering A., Heidemann J., et al. Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury. Hepatology 2004, 40:1078-1087.
11. Yilmaz Y., Dolar E., Ulukaya E., et al. Elevated serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) in patients with nonalcoholic steatohepatitis and chronic hepatitis C. Med Sci Monit 2009, 15:CR189-CR193.
12. Papatheodoridis G.V., Hadziyannis E., Tsochatzis E., et al. Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection. Gut 2008, 57:500-506.
13. Lok A.S., McMahon B.J. Practice Guidelines Committee, American Association for the Study of Liver Diseases. Chronic hepatitis B. Hepatology 2001, 34:1225-1241.
14. Ishak K., Baptista A., Bianchi L., et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995, 22:696-699.
15. Akobeng A.K. Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr 2007, 96:644-647.
16. Christensen E. Methodology of diagnostic tests in hepatology. Ann Hepatol 2009, 8:177-183.
17. EASL international consensus conference on hepatitis B. J Hepatol 2003;39:S3-S25. doi:10.1016/S0168-8278(03)00378-7.
18. Sharma S.K., Saini N., Chwla Y. Hepatitis B virus: inactive carriers. Virol J 2005, 2:82.
19. Perillo R.P. Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease. Gastroenterology 2001, 120:1009-1022.